Manufacturer · Sweden
Curovir AB
imported
About
Curovir AB is a privately-held Swedish biopharmaceutical company founded in 2017 that develops novel broad-spectrum antiviral treatments for enterovirus infections and evaluates pleconaril's effects on type 1 diabetes.
- Products: The company focuses on the candidate substance CUR-N399, which targets enteroviruses and respiratory syncytial virus (RSV).
- Industries: Its work addresses medical conditions such as COPD exacerbations, hand foot and mouth disease, poliomyelitis, and asthma.
- Operations: Curovir collaborates with researchers at Oslo University Hospital to assess antiviral efficacy in specific patient populations.
The firm serves as a potential rescue treatment for outbreaks of serious EV strains like poliovirus and EV-D68.